DNA

Ginkgo Bioworks Holdings Stock Analysis

AI Rating

Low
  • Quality0/10
  • Growth↑ 7/10
  • Value↓ 0/10
Ginkgo Bioworks Holdings sales and earnings growth
DNA Growth
Good
  • Revenue Y/Y↓ -37.84%
  • EPS Y/Y↑ 40.11%
  • FCF Y/Y↑ 51.36%
Ginkgo Bioworks Holdings gross and profit margin trends
DNA Profitability
Low
  • Gross margin ↑ 73.10%
  • EPS margin↓ -215.40%
  • ROIC 5Y↓ -62.00%
Ginkgo Bioworks Holdings net debt vs free cash flow
DNA Risk
Great
  • Debt / Equity↓ 0.9
  • Debt / FCF↓ 1.6
  • Interest coverage↓ NA

Ginkgo Bioworks Holdings stock volatility is higher than the overall market. We give it a Great risk rating.

↗ More Biotechnology stocks